AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 12100776
Drug: Valdecoxib 10
RxNorm normalized name: valdecoxib 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib 10 mg once daily
Trial: 12100776
Drug: Valdecoxib 20
RxNorm normalized name: valdecoxib 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib 20 mg once daily
Trial: 12100776
Drug: Valdecoxib 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valdecoxib 5 mg once daily
Trial: 7564369
Drug: moexipril 3.75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moexipril 3.75 mg o.d.
Trial: 7564369
Drug: moexipril 7.5
RxNorm normalized name: moexipril 7.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moexipril 7.5 mg o.d.
Trial: 7564369
Drug: moexipril 15
RxNorm normalized name: moexipril 15 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moexipril 15 mg o.d.
Trial: 2187173
Drug: Neonatal screening
RxNorm normalized name: Foreskin fibroblast (neonatal)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neonatal screening using IRT cutoff of 180 ng/mL
Trial: 6617280
Drug: heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: heparin and hydrocortisone
Trial: 31462121
Drug: 595 nm
RxNorm normalized name: NM-004
DrugBank: NM-004 (DB18066)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 595 nm pulsed-dye-laser (PDL) treatment (3 treatments, 10 mm spot size, 0.45 ms, 6 J/cm2)
Trial: 24460536
Drug: Incentive-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Incentive-based intervention including targeted education on myopia, structured weekend outdoor activities, and incentives for increasing daily steps via pedometers.
Trial: 23278322
Drug: Diflubenzuron, Eprinomectin,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diflubenzuron, Eprinomectin, Fipronil, Ivermectin (feed-through treatments)
Trial: 19888949
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (FCM) 15 mg/kg, maximum 1000 mg over 15 minutes
Trial: 12852706
Drug: Glipizide/metformin 5/500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glipizide/metformin 5/500 mg tablets
Trial: 12852706
Drug: Glipizide 30
RxNorm normalized name: Glipizide
DrugBank: Glipizide (DB01067)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glipizide 30 mg
Trial: 12852706
Drug: Metformin 2000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 2000 mg
Trial: 10587555
Drug: Sclerosing injections
RxNorm normalized name: SCLEROSING AGENTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sclerosing injections (dextrose-glycerine-phenol with lignocaine)
Trial: 10587555
Drug: Placebo injections
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo injections (saline plus lignocaine)
Trial: 8945675
Drug: Sustained-release isosorbide-5-mononitrate
RxNorm normalized name: Isosorbide 5-mononitrate
DrugBank: Isosorbide mononitrate (DB01020)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sustained-release isosorbide-5-mononitrate
Trial: 31564513
Drug: Telmisartan 80
RxNorm normalized name: telmisartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telmisartan 80 mg and Amlodipine 10 mg co-administration
Trial: 31564513
Drug: Hydrochlorothiazide 25
RxNorm normalized name: hydrochlorothiazide 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide 25 mg alone
Trial: 31564513
Drug: Co-administration of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Co-administration of all 3 drugs
Trial: 28142075
Drug: 20 mg/day
RxNorm normalized name: futibatinib 20 mg/day (4 mg x 5) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg/day rosuvastatin (n = 24)
Trial: 28142075
Drug: 80 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/day atorvastatin (n = 21)
Trial: 28142075
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (LDL‐C <3.37 mmol/L)
Trial: 27464953
Drug: Multimodal Rehabilitation
RxNorm normalized name: GLUTATHIONE 12.5 g in 100 mL ORAL LIQUID [K2LTS Brain Rehabilitation]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multimodal Rehabilitation Program (MRP) consisting of graded exposure module or a combination module of graded exposure and physical training, with a parent module added. Treatment duration varies between 7 and 16 weeks.
Trial: 25124237
Drug: HPV vaccine
RxNorm normalized name: HPV vaccine 9-valent/PF 0.5 mL INTRAMUSC VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HPV vaccine (three doses)
Trial: 19678773
Drug: Verum acupuncture
RxNorm normalized name: Cinnamomum verum whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verum acupuncture + 10 mg/day fluoxetine + placebo
Trial: 19678773
Drug: Sham acupuncture
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham acupuncture + 20‐30 mg/day fluoxetine
Trial: 11431189
Drug: Gabapentin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (200 to 300 mg after each hemodialysis session)
Trial: 2783939
Drug: Interferon alfa-2a
RxNorm normalized name: Interferon Alfa-2A
DrugBank: Interferon alfa-2a (DB00034)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferon alfa-2a (3 million IU to 36 million IU intramuscularly daily for 10 weeks)
Trial: 1097480
Drug: Protriptyline 10
RxNorm normalized name: protriptyline 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protriptyline 10 mg three times a day
Trial: 1097480
Drug: Perphenazine 2
RxNorm normalized name: perphenazine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perphenazine 2 mg three times a day
Trial: 1097480
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of protriptyline and perphenazine
Trial: 25737169
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy (lansoprazole, amoxicillin, and clarithromycin for 14 days)
Trial: 25737169
Drug: Standard triple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard triple therapy plus probiotics (Lactobacillus casei, Lactobacillus acidophilus, and Bifidobacterium lactis)
Trial: 21477426
Drug: Olopatadine 0.6%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olopatadine 0.6% nasal spray (1 spray/nostril twice-daily)
Trial: 21477426
Drug: Placebo (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (1 spray/nostril twice-daily)
Trial: 14626291
Drug: Hylan G‐F
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hylan G‐F 20 (Synvisc®)
Trial: 27349698
Drug: Edoxaban (higher-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Edoxaban (higher-dose edoxaban regimen; 60 mg dose-reduced to 30 mg once daily)
Trial: 22805873
Drug: Hypothermic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypothermic treatment (H)
Trial: 22805873
Drug: Normothermic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normothermic treatment (N)
Trial: 12569112
Drug: Konjac glucomannan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Konjac glucomannan (KGM) supplement (3.6 g/day) for 28 days
Trial: 9139554
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of fluconazole per week
Trial: 8229393
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid solution (4.8%) used as a mouthwash
Trial: 3100353
Drug: Oral acyclovir
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral acyclovir 200 mg 4 times a day
Trial: 30042362
Drug: Greek mountain
RxNorm normalized name: mountain pepper whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Greek mountain tea 950 mg
Trial: 30042362
Drug: Greek mountain
RxNorm normalized name: mountain pepper whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Greek mountain tea 475 mg
Trial: 30042362
Drug: Greek mountain
RxNorm normalized name: mountain pepper whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Greek mountain tea 475 mg and 950 mg
Trial: 30042362
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba 240 mg
Trial: 26760452
Drug: Scheduled SMS
RxNorm normalized name: Samarium Sm-153
DrugBank: Samarium Sm-153 (DB12905)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Scheduled SMS reminders (daily for 1 month, weekly for 2 months)
Trial: 24951991
Drug: Microencapsulated fish
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microencapsulated fish oil (3 g/day containing 0.41 g/day of eicosapentaenoic acid and decosahexaneoic acid)
Trial: 22313884
Drug: External methods
FDA approved: no
EMA approved: no
PMDA approved: no
Description: External methods of traditional Chinese medicine (TCM)
Trial: 18717873
Drug: 5% doxepin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% doxepin hydrochloride cream
Trial: 12798825
Drug: Beta-blockers (metoprolol,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (metoprolol, bisoprolol, carvedilol)
Trial: 12798825
Drug: Beta-blockers (CIBIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blockers (CIBIS II trial)
Trial: 10230185
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of atypical antipsychotics and psychosocial interventions
Trial: 6310997
Drug: Amdinocillin plus
RxNorm normalized name: amdinocillin
DrugBank: Amdinocillin (DB01163)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amdinocillin plus a beta-lactam antibiotic
Trial: 6310997
Drug: Aminoglycoside plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminoglycoside plus a beta-lactam antibiotic
Trial: 27350625
Drug: Mirabegron (160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron (160 mg once daily) with Metformin (500 mg twice daily)
Trial: 27350625
Drug: Mirabegron (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron (100 mg once daily) with Warfarin (25 mg)
Trial: 27350625
Drug: Mirabegron (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron (100 mg once daily) with Digoxin (0.25 mg)
Trial: 27350625
Drug: Mirabegron (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron (100 mg once daily) with COC (30/150 µg once daily)
Trial: 27350625
Drug: Mirabegron (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron (100 mg once daily)
Trial: 26496210
Drug: 2 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 μg of paricalcitol
Trial: 26496210
Drug: Treated groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treated groups (1 or 2 μg of paricalcitol)
Trial: 24341367
Drug: FL‐PDT (Fractional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FL‐PDT (Fractional laser-assisted photodynamic therapy)
Trial: 24341367
Drug: MAL‐PDT (Methyl
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAL‐PDT (Methyl aminolevulinate photodynamic therapy)
Trial: 19615128
Drug: Sequential non-invasive
RxNorm normalized name: Tavist Non-Sedating
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential non-invasive mechanical ventilation following short-term invasive mechanical ventilation
Trial: 11489325
Drug: Reference immediate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference immediate release formulation
Trial: 9430568
Drug: Morphine 2
RxNorm normalized name: apomorphine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 2 mg (Group A1)
Trial: 9430568
Drug: Preoperative Morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative Morphine 2 mg (Group A2)
Trial: 9430568
Drug: Morphine 5
RxNorm normalized name: ethylmorphine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 5 mg (Group A3)
Trial: 9430568
Drug: Preoperative Morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative Morphine 5 mg (Group A4)
Trial: 9430568
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% 20 ml (Group A5)
Trial: 9430568
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% 20 ml + Morphine 2 mg (Group A6)
Trial: 9430568
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution 20 ml (Group A7)
Trial: 9430568
Drug: Morphine 5
RxNorm normalized name: ethylmorphine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 5 mg (Group B2)
Trial: 9430568
Drug: Preoperative Morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative Morphine 5 mg (Group B3)
Trial: 9430568
Drug: Bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine 0.25% 20 ml + Morphine 2 mg (Group B5)
Trial: 9430568
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution 20 ml (Control Group)
Trial: 8512099
Drug: Intramuscular dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular dexmedetomidine (2.5 micrograms/kg) administered 60 min before induction (DEXPLA group, n = 64)
Trial: 8512099
Drug: Intramuscular dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular dexmedetomidine (2.5 micrograms/kg) and intravenous fentanyl (1.5 micrograms/kg) (DEXFENT group, n = 64)
Trial: 8512099
Drug: Intramuscular midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intramuscular midazolam (0.08 mg/kg) and intravenous fentanyl (1.5 micrograms/kg) (MIDFENT group, n = 64)
Trial: 3582167
Drug: SADS-L
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SADS-L
Trial: 3582167
Drug: DIS and
RxNorm normalized name: di-isopropylammonium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DIS and SADS-L
Trial: 29374672
Drug: rfMDA (presumptive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rfMDA (presumptive treatment with artemether-lumefantrine)
Trial: 29374672
Drug: RACD (rapid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RACD (rapid diagnostic testing and treatment using artemether-lumefantrine)
Trial: 22781525
Drug: Ultrasound guidance
RxNorm normalized name: ULTRASOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound guidance for ilioinguinal or iliohypogastric nerve block with 0.8% lidocaine and 0.25% levobupivacaine at 0.2 ml/kg (Group U)
Trial: 22781525
Drug: Traditional method
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional method of anatomical localization with 0.3 ml/kg of the same local anesthetic (Group T)
Trial: 18669967
Drug: Eprex (pre‐operative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eprex (pre‐operative injections of epoetin)
Trial: 15753747
Drug: Hypertonic saline
RxNorm normalized name: ENTSOL Hypertonic Saline Nasal Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic saline dextran (HSD) 250 mL
Trial: 15753747
Drug: Conventional fluid
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fluid regimen with hydroxyethyl starch in normal saline solution (H-NS) 250 mL
Trial: 12704010
Drug: Internet intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Internet intervention (Web site plus 12 weekly e‐mail tip sheets)
Trial: 9814858
Drug: Therapy-naive patients
RxNorm normalized name: lansoprazole
DrugBank: Lansoprazole (DB00448)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Therapy-naive patients
Trial: 7735716
Drug: Dietary and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dietary and pharmacologic agents
Trial: 62998
Drug: Dapsone 5
RxNorm normalized name: dapsone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone 5 mg daily
Trial: 62998
Drug: Dapsone 50
RxNorm normalized name: dapsone 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone 50 mg daily
Trial: 28816833
Drug: Erythromycin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin (25 mg/kg before and after surgery)
Trial: 19780000
Drug: Thiocolchicoside ointment
RxNorm normalized name: thiocolchicoside
DrugBank: Thiocolchicoside (DB11582)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiocolchicoside ointment applied onto the trigger points
Trial: 19780000
Drug: 8 mg
RxNorm normalized name: alloin 8 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 8 mg thiocolchicoside intramuscular injection to the trigger points
Trial: 19780000
Drug: Both thiocolchicoside
RxNorm normalized name: thiocolchicoside
DrugBank: Thiocolchicoside (DB11582)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both thiocolchicoside ointment and intramuscular injection
Trial: 11735185
Drug: Aspirin (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (150 mg) and below-knee compression stockings (Class 1 profile)
Trial: 11735185
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no aspirin or stockings)
Trial: 8315162
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment (standard nutrition care for subjects with IDDM)
Trial: 8315162
Drug: SHAPEDOWN program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SHAPEDOWN program and Standard treatment
Trial: 3830242
Drug: Felodipine 10
RxNorm normalized name: felodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 10 mg b.d.
Trial: 3830242
Drug: Metoprolol 100
RxNorm normalized name: metoprolol 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol 100 mg b.d.
Trial: 3830242
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of felodipine and metoprolol
Trial: 22057073
Drug: Clonazepam (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (5 mg to 10 mg)
Trial: 22057073
Drug: Zolpidem (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolpidem (1 mg)
Trial: 11915778
Drug: High-carbohydrate diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-carbohydrate diet (CD; 9-10 g carbohydrate/kg lean body mass)
Trial: 11915778
Drug: Habitual diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Habitual diet (HD; 6-7 g carbohydrate/kg lean body mass)
Trial: 8056728
Drug: Clozapine (mean
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clozapine (mean sixth week daily dose 370 mg)
Trial: 31809216
Drug: AR19 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR19 5 mg
Trial: 31809216
Drug: AR19 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR19 20 mg (intact capsule with meal)
Trial: 31809216
Drug: AR19 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR19 20 mg (fasted)
Trial: 31809216
Drug: AR19 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AR19 30 mg
Trial: 28691360
Drug: 10% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10% lidocaine spray applied to the ectocervix
Trial: 16562643
Drug: Ciprofibrat 100
RxNorm normalized name: ciprofibrate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofibrat 100 mg
Trial: 4059666
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP) 100 micrograms qds
Trial: 22166561
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (peginterferon alfa-2a 180 µg/week + ribavirin 1,000/1,200 mg/day + amantadine 200 mg/day)
Trial: 20969664
Drug: Hyaluronic acid
RxNorm normalized name: hyaluronic acid
DrugBank: Hyaluronic acid (non-animal stabilized) (DB19175)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyaluronic acid filler injections
Trial: 17377646
Drug: Pharmaceutical industry
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pharmaceutical industry sponsorship
Trial: 9041968
Drug: Intrapleural streptokinase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrapleural streptokinase (SK), 250,000 U in saline solution, mean duration 5.3 days
Trial: 3296288
Drug: Nifedipine (30-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine (30-80 mg)
Trial: 3296288
Drug: Verapamil (120-360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (120-360 mg)
Trial: 3296288
Drug: Phendilin (150-300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phendilin (150-300 mg)
Trial: 23455663
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (clinical drug treatment with Methotrexate, Leflunomide and/or Prednisone)
Trial: 20520603
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of ephedra dry extract
Trial: 20520603
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of ephedra dry extract
Trial: 18799032
Drug: Concurrent chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemoradiotherapy (RT+BP, RT+TP, RT+FP)